Testosterone levels around prostate surgery and recovery outcomes
Treatments studied
Part of Cancer, Hormones & metabolism, Kidney & urinary clinical trials.
This trial studies whether testosterone levels before and around radical prostate surgery affect cancer control and sexual/physical recovery. It may help doctors understand who benefits from testosterone replacement and who should not.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man age 18 or older.
- You have prostate cancer confirmed by biopsy, and you had radical prostatectomy as your first main treatment.
- Your surgery included at least one nerve-sparing side (to help preserve sexual function).
- Your cancer is not metastatic (no spread to distant sites), based on imaging and/or prediction tools.
- Your PSA is very low (undetectable, <0.1) within 6 weeks after surgery.
- You have low testosterone based on blood tests on two separate days, with certain hormone patterns.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether tamoxifen (a hormone-blocking medication) can help men's testosterone levels recover after they finish androgen deprivation therapy (ADT)—a common prostate cancer treatment that lowers testosterone. The goal is to see if tamoxifen can safely speed up testosterone recovery and improve quality of life.
This trial tests a penile rehabilitation program for men who have nerve-sparing prostate cancer surgery. It aims to help improve erections and sexual function after the procedure.
This Phase 2 study tests how safe and effective a topical medicine (BZ371A) is for men after prostate surgery, with the goal of improving sexual recovery and monitoring side effects. You may be able to join if you meet specific timing, health, and medication criteria after radical prostatectomy.
This trial tests whether giving hormone therapy (androgen deprivation therapy) before surgery can improve outcomes for men with high-risk prostate cancer. You will receive a special PSMA PET/CT scan to see how the cancer responds.
This study tests whether testosterone replacement therapy can safely improve low testosterone levels in men with low-risk prostate cancer who are not getting immediate treatment. It aims to help men feel better without worsening their cancer.
This trial tests a short course of 'epigenetic therapy' (drugs that change how genes work) given before prostate removal surgery. The goal is to see if it can improve treatment effects and help shrink or control the tumor.
Hear when a new Prostatic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.